


Healthcare News Roundup: Ophthalmology
HSMN NewsFeed - 6 Jan 2014
Kala Pharmaceuticals Appoints Howard B. Rosen as Chairman of the Board of Directors
Kala Pharmaceuticals Appoints Howard B. Rosen as Chairman of the Board of Directors
HSMN NewsFeed - 3 Jan 2014
RegeneRx Receives Orphan Drug Designation for Tβ4 in the Treatment of Neurotrophic Keratopathy
RegeneRx Receives Orphan Drug Designation for Tβ4 in the Treatment of Neurotrophic Keratopathy
HSMN NewsFeed - 30 Dec 2013
OphthaliX Announces Top-Line Results of Phase III Study with CF101 for Dry Eye Syndrome
OphthaliX Announces Top-Line Results of Phase III Study with CF101 for Dry Eye Syndrome
